Cogent Biosciences, Inc. (COGT)
36.37
-0.98
(-2.62%)
USD |
NASDAQ |
Apr 10, 16:00
35.86
-0.51
(-1.40%)
Pre-Market: 08:40
Cogent Biosciences EPS Diluted (Quarterly) : -0.6934 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Syndax Pharmaceuticals, Inc. | -0.7786 |
| Vera Therapeutics, Inc. | -1.395 |
| Terns Pharmaceuticals, Inc. | -0.2395 |
| Nuvalent, Inc. | -1.585 |
| Insmed, Inc. | -1.538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -102.49M |
| Total Expenses (Quarterly) | 102.49M |
| Enterprise Value | 5.331B |
| Earnings Yield | -6.73% |
| Normalized Earnings Yield | -6.638 |